 <h1>Pepcid Oral Suspension Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>famotidine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about famotidine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Pepcid Oral Suspension.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to famotidine: oral powder for suspension, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, famotidine (the active ingredient contained in Pepcid Oral Suspension) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking famotidine:</p><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>bleeding gums</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>blood in the urine or stools</li>
<li>bloody, black, or tarry stools</li>
<li>cough</li>
<li>difficulty breathing</li>
<li>discouragement</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling sad or empty</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>loss of interest or pleasure</li>
<li>noisy breathing</li>
<li>pinpoint red spots on the skin</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>seizures</li>
<li>swelling around the eyes</li>
<li>tightness in the chest</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>unusual bleeding or bruising</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>blistering, peeling, or loosening of the skin</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain</li>
<li>chills</li>
<li>clay-colored stools</li>
<li>dark urine</li>
<li>diarrhea</li>
<li>difficulty swallowing</li>
<li>dizziness or fainting</li>
<li>fever</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>high fever</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>joint or muscle pain</li>
<li>large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>light-colored stools</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>stomach pain</li>
<li>swollen glands</li>
<li>unpleasant breath odor</li>
<li>unusual tiredness or weakness</li>
<li>upper right abdominal pain</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of famotidine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Difficulty having a bowel movement</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bad, unusual, or unpleasant (after) taste</li>
<li>bone or muscle pain</li>
<li>change in taste</li>
<li>continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>decreased interest in sexual intercourse</li>
<li>difficulty in moving</li>
<li>dry mouth</li>
<li>dry skin</li>
<li>feeling of warmth</li>
<li>hearing loss</li>
<li>inability to have or keep an erection</li>
<li>lack or loss of strength</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>muscle pain or stiffness</li>
<li>redness of the face, neck, arms and occasionally, upper chest</li>
<li>redness of the white part of the eyes</li>
<li>stomach discomfort</li>
<li>unusual drowsiness</li>
</ul><p>
<!-- end oral powder for suspension, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to famotidine: compounding powder, intravenous solution, oral powder for reconstitution, oral tablet, oral tablet chewable, oral tablet disintegrating</i></p><h3>General</h3><p>The most commonly reported side effects include headache, dizziness, constipation, and diarrhea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, diarrhea</p>
<p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting, flatulence, dry mouth, abdominal discomfort or distension<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Convulsions occurred in patients with renal dysfunction.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Very rare</b> (less than 0.01%): Paresthesia, somnolence, epileptic seizures, convulsion</p>
<p><b>Frequency not reported</b>: Grand mal seizure, taste disorder<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus</p>
<p><b>Rare</b> (0.01% to 0.1%): Urticaria, angioneurotic edema</p>
<p><b>Very rare</b> (less than 0.01%): Alopecia, severe skin reactions, toxic epidermal necrolysis, Stevens-Johnson syndrome, epidermal necrolysis</p>
<p><b>Frequency not reported</b>: Acne, dry skin, flushing<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Fatigue</p>
<p><b>Frequency not reported</b>: Asthenia, fatigue, facial/orbital edema, tinnitus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Loss of appetite</p>
<p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Thrombocytopenia, leukopenia, agranulocytosis, pancytopenia</p>
<p><b>Frequency not reported</b>: Neutropenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (0.01% to 0.1%): Intrahepatic cholestasis, jaundice, increased liver enzyme abnormalities (transaminases, gamma GT, alkaline phosphatase, bilirubin)</p>
<p><b>Frequency not reported</b>: Cholestatic jaundice, hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Hypersensitivity reactions, anaphylaxis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Bronchospasm</p>
<p><b>Frequency not reported</b>: Interstitial pneumonia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (0.01% to 0.1%): Arthralgia</p>
<p><b>Very rare</b> (less than 0.01%): Muscle cramps</p>
<p><b>Frequency not reported</b>: Rhabdomyolysis, musculoskeletal pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>When patients obtained follow-up, psychic disturbances were found to be reversible.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Hallucinations, disorientation, confusion, anxiety, agitation, depression, reduced libido, insomnia</p>
<p><b>Frequency not reported</b>: Psychic disturbances<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>QT interval prolongation occurred in patients with renal dysfunction.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Chest tightness, prolonged QT interval</p>
<p><b>Frequency not reported</b>: Arrhythmia, atrioventricular block, palpitation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very rare</b> (less than 0.01%): Impotence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Conjunctival injection<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Gynecomastia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Pepcid (famotidine)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Pepcid AC (famotidine)." Johnson and Johnson/Merck, Fort Washington, PA. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Pepcid Oral Suspension (famotidine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: H2 antagonists</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Heartburn Relief</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Pepcid</li>
<li>Pepcid AC</li>
<li>Pepcid Complete</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Duodenal Ulcer</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li>Erosive Esophagitis</li>
<li>GERD</li>
<li data-more-config-id="list-data-resources-conditions">... +6 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to famotidine: compounding powder, intravenous solution, oral powder for reconstitution, oral tablet, oral tablet chewable, oral tablet disintegrating</i></p><h3>General</h3><p>The most commonly reported side effects include headache, dizziness, constipation, and diarrhea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, diarrhea</p><p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting, flatulence, dry mouth, abdominal discomfort or distension<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Convulsions occurred in patients with renal dysfunction.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Very rare</b> (less than 0.01%): Paresthesia, somnolence, epileptic seizures, convulsion</p><p><b>Frequency not reported</b>: Grand mal seizure, taste disorder<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus</p><p><b>Rare</b> (0.01% to 0.1%): Urticaria, angioneurotic edema</p><p><b>Very rare</b> (less than 0.01%): Alopecia, severe skin reactions, toxic epidermal necrolysis, Stevens-Johnson syndrome, epidermal necrolysis</p><p><b>Frequency not reported</b>: Acne, dry skin, flushing<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Fatigue</p><p><b>Frequency not reported</b>: Asthenia, fatigue, facial/orbital edema, tinnitus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Loss of appetite</p><p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Thrombocytopenia, leukopenia, agranulocytosis, pancytopenia</p><p><b>Frequency not reported</b>: Neutropenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (0.01% to 0.1%): Intrahepatic cholestasis, jaundice, increased liver enzyme abnormalities (transaminases, gamma GT, alkaline phosphatase, bilirubin)</p><p><b>Frequency not reported</b>: Cholestatic jaundice, hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Hypersensitivity reactions, anaphylaxis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Bronchospasm</p><p><b>Frequency not reported</b>: Interstitial pneumonia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (0.01% to 0.1%): Arthralgia</p><p><b>Very rare</b> (less than 0.01%): Muscle cramps</p><p><b>Frequency not reported</b>: Rhabdomyolysis, musculoskeletal pain<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>When patients obtained follow-up, psychic disturbances were found to be reversible.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Hallucinations, disorientation, confusion, anxiety, agitation, depression, reduced libido, insomnia</p><p><b>Frequency not reported</b>: Psychic disturbances<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>QT interval prolongation occurred in patients with renal dysfunction.<sup>[Ref]</sup></p><p><b>Very rare</b> (less than 0.01%): Chest tightness, prolonged QT interval</p><p><b>Frequency not reported</b>: Arrhythmia, atrioventricular block, palpitation<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very rare</b> (less than 0.01%): Impotence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Conjunctival injection<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Gynecomastia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Pepcid (famotidine)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Pepcid AC (famotidine)." Johnson and Johnson/Merck, Fort Washington, PA. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Pepcid Oral Suspension (famotidine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: H2 antagonists</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Pepcid</li>
<li>Pepcid AC</li>
<li>Pepcid Complete</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Duodenal Ulcer</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li>Erosive Esophagitis</li>
<li>GERD</li>
<li data-more-config-id="list-data-resources-conditions">... +6 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>